Yusuke Naito

6PUBLICATIONS
10CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2025
Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by age.

Kazuhiro Yamamoto, Yusuke Naito, Sakurako Watanabe

|Jan 24, 2025
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J-DREAMS database.

Mitsuru Ohsugi, Daisuke Nitta, Yusuke Naito

|May 17, 2023
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study.

Kohei Kaku, Yayoi Nakayama, Junko Yabuuchi

|Mar 12, 2021
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.

Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda

|Dec 03, 2020
Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance.

Tomohiro Ito, Yusuke Naito, Naoki Shimmoto

|Mar 28, 2017
Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study).

Yuichiro Yamada, Masayuki Senda, Yusuke Naito

Pageof 1

Frequent Collaborators

2 joint publications

Kohei Kaku

1 joint publications

Tomohiro Ito

1 joint publications

Yayoi Nakayama

1 joint publications

Junko Yabuuchi